These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31182324)

  • 1. Regional variations in human papillomavirus prevalence across time in NHANES (2003-2014).
    Hirth JM; Kuo YF; Starkey JM; Rupp RE; Laz TH; Rahman M; Berenson AB
    Vaccine; 2019 Jul; 37(30):4040-4046. PubMed ID: 31182324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of human papillomavirus vaccination on racial/ethnic disparities in vaccine-type human papillomavirus prevalence among 14-26 year old females in the U.S.
    Hirth J; McGrath CJ; Kuo YF; Rupp RE; Starkey JM; Berenson AB
    Vaccine; 2018 Nov; 36(50):7682-7688. PubMed ID: 30377066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation in genital human papillomavirus infection prevalence and vaccination coverage among men and women in the USA.
    Han JJ; Tarney CM; Song J
    Future Oncol; 2017 Jun; 13(13):1129-1132. PubMed ID: 28589730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine - United States, 2003-2018.
    Rosenblum HG; Lewis RM; Gargano JW; Querec TD; Unger ER; Markowitz LE
    MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(12):415-420. PubMed ID: 33764964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring vaccine and non-vaccine HPV type prevalence in the post-vaccination era in women living in the Basilicata region, Italy.
    Carozzi F; Puliti D; Ocello C; Anastasio PS; Moliterni EA; Perinetti E; Serradell L; Burroni E; Confortini M; Mantellini P; Zappa M; Dominiak-Felden G
    BMC Infect Dis; 2018 Jan; 18(1):38. PubMed ID: 29334901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010.
    Markowitz LE; Hariri S; Lin C; Dunne EF; Steinau M; McQuillan G; Unger ER
    J Infect Dis; 2013 Aug; 208(3):385-93. PubMed ID: 23785124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geographical disparities in human papillomavirus herd protection.
    Berenson AB; Hirth JM; Chang M
    Cancer Med; 2020 Jul; 9(14):5272-5280. PubMed ID: 32483924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of Any and Vaccine-Type Anogenital Human Papillomavirus Among 13-26-Year-Old Young Men After HPV Vaccine Introduction.
    Chandler E; Ding L; Gorbach P; Franco EL; Brown DA; Widdice LE; Bernstein DI; Kahn JA
    J Adolesc Health; 2018 Jul; 63(1):43-49. PubMed ID: 30060856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of oral human papillomavirus by vaccination status among young adults (18-30years old).
    Hirth JM; Chang M; Resto VA;
    Vaccine; 2017 Jun; 35(27):3446-3451. PubMed ID: 28526331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Human Papillomavirus Vaccination on Prevalence of Vaccine Genotypes in Young Sexually Active Women in France.
    Heard I; Tondeur L; Arowas L; Demazoin M; Falguières M; Parent Du Chatelet I;
    J Infect Dis; 2017 Mar; 215(5):757-763. PubMed ID: 28011911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV vaccination among adolescent females from Appalachia: implications for cervical cancer disparities.
    Reiter PL; Katz ML; Paskett ED
    Cancer Epidemiol Biomarkers Prev; 2012 Dec; 21(12):2220-30. PubMed ID: 23136141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of HPV prevalence between HPV-vaccinated and non-vaccinated young adult women (20-26 years).
    Guo F; Hirth JM; Berenson AB
    Hum Vaccin Immunother; 2015; 11(10):2337-44. PubMed ID: 26376014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mothers' acceptance of human papillomavirus (HPV) vaccination for daughters in a country with a high prevalence of HPV.
    Alder S; Gustafsson S; Perinetti C; Mints M; Sundström K; Andersson S
    Oncol Rep; 2015 May; 33(5):2521-8. PubMed ID: 25738832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acceptability of vaccination against human papillomavirus (HPV) by pediatricians, mothers and young women in Ho Chi Minh City, Vietnam].
    Phan DP; Pham QT; Strobel M; Tran DS; Tran TL; Buisson Y
    Rev Epidemiol Sante Publique; 2012 Dec; 60(6):437-46. PubMed ID: 23137871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction.
    Covert C; Ding L; Brown D; Franco EL; Bernstein DI; Kahn JA
    Hum Vaccin Immunother; 2019; 15(7-8):1962-1969. PubMed ID: 30633598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Genital Human Papillomavirus Infection and Human Papillomavirus Vaccination Rates Among US Adult Men: National Health and Nutrition Examination Survey (NHANES) 2013-2014.
    Han JJ; Beltran TH; Song JW; Klaric J; Choi YS
    JAMA Oncol; 2017 Jun; 3(6):810-816. PubMed ID: 28114440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Awareness and Knowledge About HPV and HPV Vaccine Among Romanian Women.
    Grigore M; Teleman SI; Pristavu A; Matei M
    J Cancer Educ; 2018 Feb; 33(1):154-159. PubMed ID: 27830570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decline in vaccine-type human papillomavirus prevalence in young men from a Midwest metropolitan area of the United States over the six years after vaccine introduction.
    Widdice LE; Bernstein DI; Franco EL; Ding L; Brown DR; Ermel AC; Higgins L; Kahn JA
    Vaccine; 2019 Oct; 37(45):6832-6841. PubMed ID: 31582269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Vaccine-Type Human Papillomavirus Prevalence After Vaccine Introduction: No Evidence for Type Replacement but Evidence for Cross-Protection.
    Saccucci M; Franco EL; Ding L; Bernstein DI; Brown D; Kahn JA
    Sex Transm Dis; 2018 Apr; 45(4):260-265. PubMed ID: 29465705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in Human Papillomavirus Prevalence Among U.S. Women Aged 18-59 Years, 2009-2014.
    Berenson AB; Hirth JM; Chang M
    Obstet Gynecol; 2017 Oct; 130(4):693-701. PubMed ID: 28885413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.